Figure 5.

NM inhibits the anti-inflammatory effect of DALDA. Evaluation of (a) macroscopic and (b) histologic lesions and (c) quantification of MPO levels 4 days after TNBS administration in untreated mice (black bars) and mice receiving DALDA (10^–2 mg/kg/d) (gray bars) or both NM and DALDA (white bars). The number of mice and statistical significance are indicated, and results are expressed as mean ± SEM.